• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/110

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

110 Cards in this Set

  • Front
  • Back
MPS Mycoplasmal Pneumonia of Swine


Agent
Mycoplasma hyopneumoniae
aka Enzootic pneumonia
MPS Mycoplasmal Pneumonia of Swine


Significance
Major Respiratory Pathogen NA

Contributor
Procine Respiratory Dz Complex PRDC
MPS Mycoplasmal Pneumonia of Swine


Etiology
Culture SLOW GROWTH 4 to 8 Weeks
Dx = NIET

Antimicrobial Resistance HIGH

Persistence Poor Survival Environment
MPS Mycoplasmal Pneumonia of Swine


Epidemiology
Incubation 2 to 3 Weeks

TRANSMISSION HORIZONTAL
Sow to Piglet via Crates,
Pig to Pig Nursery and Grower

REGIONAL SPREAD AEROSOL 3.2 Km
Season Winter
Cold, Wet, Light Winds

GROWER Mainly Affected > 10 WEEKS
MPS Mycoplasmal Pneumonia of Swine

Epidemiology

Epidemic
NAÏVE FARMS ACUTE OUTBREAKS Severe Disease

All Ages Affected

Pyrexia (40 to 40.5) Anorexia, Pyrexia, Lethargy

Respiratory Signs Severe Disease Extensive Lung Involvement

Death Occasionally Peracute

Abortion Occasionally Via Pyrexia
MPS Mycoplasmal Pneumonia of Swine

Epidemiology

Endemic
MOST COMMON

CHRONICALLY Infected Herds

Susceptible Pig Exposed Entering GROWER
via
Waning Maternal AB,
Shedding of Older Animals

Coughing Develops 2 to 3 Weeks Post Exposure
EARLY GROWER PERIOD

Morbidity High

Mortality Low
MPS Mycoplasmal Pneumonia of Swine

Clinical Signs
COUGH NON PRODUCTIVE
if UNCOMPLICATED
Dry Raspy

COUGH PORDUCTIVE if CONCURRENT INFECTION

SEVERITY Influenced by
Mycoplasma hyopneumoniae STRAIN
Pig Flow,
Density,
Air Quality
MPS Mycoplasmal Pneumonia of Swine


Pathogenesis
COLONIZES
TRACHEAL EPI CELLS
BRONCHIAL EPI CELLS

CLUMPS CILIA
IMPAIRS MUCOCILIARY ESCALATOR

SECONDARY INVASION
Mixed Bacterial and Viral Infections

RESOLUTION Uncomplicated Cases

INCREASED SEVERITY
Concurrent RESPIRATORY PATHOGENS
Leads to PRDC
MPS Mycoplasmal Pneumonia of Swine

Diagnosis

Pathology
BRONCHO PNEUMONIA
CRANIO VENTRAL CONSOLIDATION

Cranial, "Middle", Accessory Lobes
+/- Cranial Portion Caudal Lobes

FIRM Meaty Lungs
Red Purple

CATARRHAL EXUDATE Airway Cut Surface

MEDIASTINAL LYMPH NODES Enlarged, Edematous

PERI-BRONCHIAL LYMPHOID HYPERPLASIA (Cuffing)
Highly Suggestive

Alveoli Debris and Inflammatory Cells
MPS Mycoplasmal Pneumonia of Swine

Diagnosis
Fluorescent Antibody Test
ANTIGEN Lung
Include CILIATED Airway Epi

Immuno Histo Chemistry
ANTIGEN Lung
Include CILIATED Airway Epi

PCR Nucleic Acid
Lung,
Bronchial Fluid,
Trachea

Serology IgG ELISA
DAKO (blocking),
IDEXX (indirect)
MPS Mycoplasmal Pneumonia of Swine

Diagnosis

Serology
IgG ELISA
DAKO (blocking),
IDEXX (indirect)

MEASURES EXPOSURE
Interpretation Difficult

Seroconversion HIGHLY VARIABLE

Up to 6 WEEKS TO INDUCTION IgG

Can NOT DIFFERENTIATE
Natural Infection vs Vaccination

Correlation Vaccine Titres and Protection NIET

SPECIFICITY GOOD

SENSITIVITY LOW (DAKO Better)
MPS Mycoplasmal Pneumonia of Swine

Diagnosis

Slaughter Check
Lung Lesion Scoring
PREVELANCE AND SEVERITY

Herd Infection Probable
INDIVIDUAL LESION SCORE > 5%

Herd Infection Probable
PREVEALENCE of INFECTED LUNGS > 20%

PCR UNRELIABLE
Environmental Contamination

Proportion of AFFECTED LOBE Estimated

Score is TOTAL for All Lobes
MPS Mycoplasmal Pneumonia of Swine

Control

Vaccination Injection
Sow, Nursery, Grower

REDUCES PREVALENCE and SEVERITY

COLONIZATION NOT PREVENTED

2 to 3 Weeks PRIOR TO EXPECTED EXPOSURE
(Typically Grower)

One and Two Dose Products Available
Severity, Infection Pressure, Cost

MATERNAL AB INTERFERENCE
tf Vaccinate AFTER 6 to 8 Weeks Age
MPS Mycoplasmal Pneumonia of Swine

Control

Antimicrobial Feed
Prior or During PEAK EXPOSURE
DOES NOT ELIMINATE Mycoplasma hyopneumonia

Controls Secondary Infections Cost Effective Grower Tiamulin

Controls Secondary Infections Cost Effective Grower Chlortetracycline

Controls Secondary Infections Cost Effective Grower Lincomycin

Controls Secondary Infections Cost Effective Grower Tetracyclines

Controls Secondary Infections Cost Effective Grower Tylosine
MPS Mycoplasmal Pneumonia of Swine

Treatment

Antimicrobial

Parenteral
Secondary Infections Lincomycin

Secondary Infections Tylosine

Secondary Infections Tetracyclines

Secondary Infections Tiamulin
MPS Mycoplasmal Pneumonia of Swine

Control

Environment
Air Quality Improvements

AIAO ALWAYS Segregate Groups

Control OTHER RESPIRATORY PATHOGENS
PRRS,
PCV2,
SIV,
Streptococcus suis,
Haemophilus parasuis, etc
APP Actinobacillus Pleuropneumonia

All Forms

Etiology
Severe Disease Traditionally

Less Severe Western Canada Last 20 Years

Biotypes I and II
Typical NAD Dependent
Atypical NAD Independent

Culture NAD Supplied by Staph Streaks
Ask FOR IT

SEROTYPES 15 Count em
VARYING VIRULENCE

Serotypes 1, 5, 7
MOST VIRULENT and COMMON CANADA
APP Actinobacillus Pleuropneumonia

All Forms

Epidemiology
Transmission HORIZONTAL Primarily

Transmission AEROSOL SHORT DISTANCES

INCUBATION SHORT 6 to 12 Hours

SEVERITY Influenced by
Serotype,
Dose
Herd Immune Status, Concurrent Dz
APP Actinobacillus Pleuropneumonia

All Forms

Pathogenesis
Colonizes
TONSIL
ALVEOLAR EPI

FIMBRIAL ADHESINS Facillitate Colonization

Adherence Phagocytosis ALVEOLAR MACROPHAGES

RTX EXOTOXINS Apx I, II, III, IV
HEMOLYTIC,
CYTOTOXIC

INFLAMMATORY CYTOKINES

SEPTIC SHOCK Peracute Death

ARTERIOLAR THROMBOSIS

ALVEOLAR NECROSIS Acute Lung Lesions
APP Actinobacillus Pleuropneumonia

Peracute

Clinical Signs
Death Peracute (3 TO 36 Hours Post Infection)
Sporadic in Pigs

Tachycardia

Tachypnea
CYANOSIS
Extremities
Generalized

EPISTAXIS FOAMY
APP Actinobacillus Pleuropneumonia

Acute

Clinical Signs
Anorexia, Pyrexia, Depression > 40

DYSPNEA

COUGH

AGONAL BREATHING

Outcome Varies with Animal

Death Acute
Cardiovascular and Circulatory Collapse
APP Actinobacillus Pleuropneumonia

Chronic

Clinical Signs
COUGH CHRONIC
via CHRONIC PLEURITIS

APPETITE REDUCED

Weight Gain Impaired
APP Actinobacillus Pleuropneumonia

Peracute and Acute

Diagnosis

Pathology
Pneumonia Severe Acute Well Demarcated

Pneumonia NECROTIZING HEMORRHAGIC

Pneumonia CAUDAL LOBES (Generally)

PLEURITIS FOCAL

Trachea Blood Tinged Froth
APP Actinobacillus Pleuropneumonia

Chronic

Diagnosis

Pathology
PLEURITIS
CHRONIC ADHESIONS

CONSOLIDATION and NECROSIS FOCAL

PULMONARY ABSCESSES BLACK FOCI

FIBRIN GROUND GLASS APPEARANCE
APP Actinobacillus Pleuropneumonia

All Forms

Diagnosis
NECROTIZING HEMORRHAGIC PNEUMONIA

FOCAL PLEURITIS

PLEURAL ADHESIONS HIGH % SLAUGHTER CHECK

Culture Lung Lesions

Serotyping Lung Lesions

Serology ELISA
Screening All

Serotypes
Serology ELISA
INDIVIDUAL SEROTYPES 1, 5, 7
APP Actinobacillus Pleuropneumonia

All Forms

Control Environment
Air Quality Improvements

AIAO ALWAYS
Segregate Groups

Control OTHER RESPIRATORY PATHOGENS
PRRS,
PCV2,
SIV,
Streptococcus suis, Haemophilus parasuis, etc
APP Actinobacillus Pleuropneumonia

All Forms

Control

Antimicrobial Parenteral
Peracute and Acute Only Penicillin G

Peracute and Acute Only Tetracyclines
APP Actinobacillus Pleuropneumonia

All Forms

Control

Antimicrobial Feed
Amoxicillin

Tiamulin

Tilmicosin
APP Actinobacillus Pleuropneumonia

All Forms

Control

Antimicrobial Water
Amoxicillin

Tiamulin

Tilmicosin
APP Actinobacillus Pleuropneumonia

All Forms

Control

Vaccination Injection
BREEDING HERD

Nursery, Grower, Finisher

Protection from CLINICAL Dz +/-

Does NOT PREVENT INFECTION

Variable Value
Rarely Used Western Canada (Except Pre Entry Acclimation

Subunit and Killed Products

Serotype Specific
All Have (1,5, 7)
SIV Swine Influenza

All Forms

Significance
Zoonotic Potential
Mixed Infections MAY Lead to Reassortment with
Human, Avian and Swine Viruses
Possible Pandemic Strains - ok enough from Chicken Little

Transmission Has Been Docmented
Swine to Human
Human to Swine (More Common)
ala 1918 Pig Influenza Die Off

Swine Worker Vaccination for Seasonal Influenza
Minimize Opportunities for Reassortment

Pig Influenza Viruses Have RECEPTORS in BOTH GI and RESPIRATORY TRACTS

Spanish Flu 1918 Avian H1N1

Asian Flu 1957 - 1958 Avian H2N2 Pig Mixing Vessel

Hong Kong Flu 1968 - 1969 Avian H3N2 Pig Mixing Vessel
SIV Swine Influenza

All Forms

Agent
Type A Influenza Virus Orthomyxoviridae
Multiple Strains (H1,2,3 and N1,2,3)
SIV Swine Influenza

All Forms

Etiology
8 SEGMENTS SS RNA
SHIFT (Segment Reassortment Between Strains) = Rapid Change
DRIFT (Point Mutations) = Slow Change

Surface Glycoprotein AG
H (Hemagglutinin)
Virus Attachment,
RBC Agglutination
N (Neurominidase)
Viral Release from Infected Cells

CLASSIC SWINE H1N1
Exclusive Strain NA 1930 to 1998
Stable Genotype Due to Abundant Naïve Pigs

EUROPEAN H1N1
Uniquely Highly Pathogenic 1930 to 1998

TRIPLE REASSORTED H3N2 After 1998
A Big SMOZZLE
Genes from HUMAN, SWINE and AVIAN Viruses

THREE CLUSTERS Linked to HUMAN STRAIN

Multiple Strains Emerging
tf Must Sequence Farm's Strain(s) to Know What it Is
SIV Swine Influenza

All Forms

Epidemiology
HIGHLY INFECTIOUS Respiratory Disease
Transmission Horizontal
DIRECT CONTACT Pig to Pig Via Nasopharyngeal Secretions
AIRBORNE Hog Dense Regions

Passive Immunity
Protects Against Dz
DOES NOT Prevent Infection or Shedding

Morbidity High - 100%

Mortality Low

SHORT INCUBATION 1 to 3 Days
SIV Swine Influenza

Classic Swine H1N1

Clinical Signs
COUGING
EXPLOSIVE - Sudden Onset
PAROXYMAL
SEAL BARK - Highly Suggestive

Dyspnea

Pyrexia

PROSTRATION Piling

HIGH MORBIDITY 100%

LOW MORTALITY

Rapid Recovery 5 to 7 Day Clinical Course
SIV Swine Influenza

Modern Reassorted Strains
Clinical Signs
Less Severe Dz is Possible
POTENTIALLY SUBTLE

VARIABLE

ALL AGES AFFECTED

Herd Presentation Varies
Strain, Age, Immunity

Concurrent Dz (PRRS, MH, etc)
SIV Swine Influenza

All Forms

Pathogenesis
RAPID REPLICATION
Respiratory Tract,
Lungs,
Nasal Mucosa
Tonsil,
Lymph Nodes

BRONCHIOLAR EPITHELIUM
Highly Specific Trophism

EPITHELIAL CELL NECROSIS

Inflammation Cytokines TNF, IL-1

EXUDATE Accumulation Degenerate Mucosal Cells and Neuts

RAPID CLEARANCE of Virus
SIV Swine Influenza

All Forms

Diagnosis

Pathology
Viral Replication
Respiratory Tract ONLY

CONJUNCTIVITIS

NASAL DISCHARGE

CONSOLIDATION CRANIAL and MIDDLE Lobes
Purple Firm

Pneumonia
Bronchial / Interstitial

Cranio Ventral

+/- Hyper Inflation

EXUDATE Blood Tinged, Fibrinous

EDEMA Interlobular
SIV Swine Influenza

All Forms

Diagnosis

Histopathology
BRONCHITIS / BRONCHIOLITIS NECROTIZING
MUST HAVE

Airway Epithelium
Degeneration and Necrosis

ALVEOLI FILLED with EXUDATE
(Desquamated Cells and Neuts)
Also Bronchi, Bronchioli

Atelectasis

BRONCHIO INTERSTIIAL PNEMONIA
SIV Swine Influenza

All Forms

Diagnosis

Immuno Histo Chemistry
AG Detection Type A
(tf ALL SPECIES)
Lung,
Nasal Swabs

< 8 DAYS ONLY

> 8 Days = False Negative
SIV Swine Influenza

All Forms

Diagnosis

PCR
Nucleic Acid
Lung,
Nasal Swabs

< 8 DAYS ONLY

> 8 Days = False Negative
SIV Swine Influenza

All Forms

Diagnosis

Serology
HI (Paired Samples)

ELISA

SENSITIVITY VARIES
via Specific Strain Used in Assay

HOMOLOGOUS STRAINS = HIGHER TITRES

Stain Specific Assays Can be Developed

GENETIC ANALYSIS or SEQUENCING
+ve = USEFULL INFROMMATION
ie Determine Usefullness of Commerial Vaccines
-ve = LITTLE INFROMATION
SIV Swine Influenza

All Forms

Diagnosis

Time Line
24 Hours Post Infection
Peak Fever

48 Hours Post Infection
Peak Excretion
(Good TIME to SAMPLE)
Coughing Starts

6 to 8 Days Post Infection
Viral Clearance

10 to 14 Days Post Infection
Seroconversion
Coughing Stops
SIV Swine Influenza

All Forms

Treatment
SUPPORTIVE Care ONLY

Antimicrobial Parenteral
SECONDARY BACTERIAL Infections
Control Concurrent Dz

Antimicrobial Feed
SECONDARY BACTERIAL Infections
Control Concurrent Dz

AIR QUALITY
Improve NH3, Dust

Sannitation
Improve
SIV Swine Influenza

All Forms

Control

Vaccination Injection
H1N1 (All), H3N2 (Most)
+/- Efficaccy

Bivalent Killed Bacterins

Generally Effective
CLASSIC H1N1

VARIABLE H3N2
Rapid Shift in Genome

AUTOGENOUS EFFECTIVE
tf Try Early

Sows Pre Farrowing

Piglets Weaning or Post Weaning
PRCV Porcine Respiratory Corona Virus


Etiology
EVOLVED FROM TGE

Genetic Mutation
Trophism for Lung Instead of GIT
PRCV Porcine Respiratory Corona Virus


Clinical Signs
ASYMTOMATIC

SUBCLINICAL

INTERSTITIAL PNEUMONIA
DIFFUSE MILD

VIREMIA
Parenchymal Organs
Lymph Nodes
PRCV Porcine Respiratory Corona Virus


Significance
Partial Protection from TGE
Masks Clincal Dz

Reduced Incidence of TGE Worldwide

CROSS REACTIONS Serologic Testing
Serum Neutralization
tf Use Competitive ELISA to Differentiate TGE/PRCV
PRDC Porcine Respiratory Dz Complex


Etiology
Multifactorial
ala Bovine Shipping Fever

Virus
Mycoplasma
2˚ Bacteria

Bacteria
Mycoplasma hyopneumoniae,
Pasteurella multocida,
Actinobacillus pleuropneumonia,
Streptococcus suis,
Haemophilus parasuis,
Actinobacillus suis

Viruses
Swine Influenza Virus,
PRRS,
PRCV,
PCV2

Parasites
Acaris suum
PRDC Porcine Respiratory Dz Complex

Diagnosis
IDENTIFICATION PRIMARY and SECONDARY PATHOGENS
CRITICAL

Detailed History and Clinical Workup

Pathology
Gross and Histology
Early Cases and Untreated

Serology
Multiple Assays
Serial Studies

Culture

PCR

Immuno Histo Chemistry
Streptococcus suis

All Forms

Significance
Emerging Disease Livestock Intensification

Stress Percipitated

35 SEROTYPES
Identified by Capsular Proteins

TYPE 2 Most Common
ZOONOTIC
Streptococcus suis

All Forms

Epidemiology
UPPER RESPIRATORY TRACT Infection
NORMAL INHABITANT
EARLY COLONIZER
Also Found
Genital Tract
Alimentary Tract

RESERVOIRS VECTORS
Many DOMESTIC SPECIES

Persistence Environment
LENGTHY Manure > 100 Days

Multiple Serotypes and or Strains On Farm

VIRULENCE VARIES with SEROTYPE

Transmission HORIZONTAL
Sow to Piglet
via GENITAL TRACT
via RESPIRATORY
via Alimentary
PIG to PIG Nurseries On

CARRIERS SOWS NEAR 100%
Streptococcus suis

Acute

Clinical Signs
CONVULSIONS Acute

Death ACUTE
Septicimia,
POLYSEROSITIS,
MENINGITIS

OPISTHOTONOUS Acute

Paddling Acute
Streptococcus suis

All Forms

Clinical Signs
WEEKS 5 to 10 PRIMARY ONSET
Streptococcus suis


Chronic

Clinical Signs
ARTHRITIS
Poly Chronic

Cyanosis
Feet,
Tails
Left Sided Endocarditis

Infarction
Peripheral Tissue

Pneumonia Broncho Pneumonia Chronic

VALVULAR ENDOCARDITIS Chronic
Streptococcus suis


Peracute

Clinical Signs
Death PERACUTE

Good Condition
Streptococcus suis


Meningitis

Pathogenesis
ENDOTHELIAL INVASION
Blood Brain Barrier

Local Inflammation

Cytokine Production INCREASED

PERMEABILITY of BBB
TRANSEDOTHELIAL MIGRATION
Neutrophils
Monocytes

LEAKAGE
Plasma Proteins Into Subarachnoid Space

CEREBRAL EDEMA
Increased Intracranial Pressure
Impaired Circulation
Streptococcus suis

Sepsis

Pathogenesis
TONSILAR and / or NASAL CAVITY
INVASION

HUMORAL IMMUNITY INEFFECTIVE

Association with Blood Monocytes

Encapsulation Resists Phagocytotic Killing
tf Serotype (Capsule) IMPORTANT

BACTEREMIA

CYTOKINES RELEASED
TNf,
IL-1,
IL-6,
IL-8

SEPTIC SHOCK
Peracute Death
Streptococcus suis


All Forms

Diagnosis

Pathology
Cerebellar Vermis Protrusion

Meningial Exudates
Subtle

Endocarditis Vegatative

Pulmonary Edema

Hepatic Congestion Chronic Passive

Suppurative Bronchopneumonias
Streptococcus suis


All Forms

Diagnosis
Clinical Signs
CONVULSIONS Most Suggestive

CULTURE
Brain,
Joints,
Parenchymal Organs
Lung = NIET

SEROTYPES
Brain,
Joints,
Parenchymal Organs
Lung = NIET

Serology Limited
Streptococcus suis


All Forms

Treatment
PROMPT
Recognition and Tx Essential
for Meningitis

ANTIBIOGRAM MONITORING
Resistance Patterns
Tetracyclines Most Strains Resistant

Antimicrobial Parenteral
Bacteriacidal = BEST
B-Lactams

Antimicrobial Parenteral
Bacteriacidal = BEST
TMS

Anti Inflammatories Parenteral Convulsions
Isoflupredone (Predef)

Anti Inflammatories Parenteral Convulsions
Dexamethazone
Streptococcus suis


All Forms

Control
Antimicrobial Water
1st Week,
Repeat 2nd Week
Penicillin G Most Common

PERCIPITATION STRESS FACTORS Control
Overcrowding,
Ventilation,
Sanitation,
Temperature,
Mixing,
Ages

Vaccination Injection GENERALLY INEFFECTIVE

Vaccination Injection
Capsular Specific AB
Facilitate Opsonization and Phagocytosis

Vaccination Injection
Must Be SEROTYPE (CAPSULE) SPECIFIC

Vaccination Injection Commerial and Autogenous
Do NOT Produce Sufficient Serum IgG

Vaccination Injection Multiple Injections Required
4 to 6 Per Pig
Streptococcus suis


Zoonosis

Significance
Rare but SEVERE Dz

TYPE 2 Most Common

MENINGITIS

Septicemia / Bacteremia

Endocarditis

Cellulitis

Arthritis

DEAFNESS
50 to 65% of Meningitis

Direct Contact with Pigs Most Common

Entry through
SKIN
WOUNDS

Hand Washing Effective

Disinfectants Effective
Glasser's Disease (Porcine Polyserositis and Arthritis)


All Forms

Agent
Haemophilus parasuis
Glasser's Disease (Porcine Polyserositis and Arthritis)

All Forms

Etiology
Emerging Disease
Has Become Significant Pathogen in Last Decade

OUTBREAKS (Naïve Farms)
ACUTE EXPLOSIVE

SEROTYPES
15 - 4, 5 and 13 Most Common NA

SEROTYPES
Most Pathogenic UNTYPABLE

Normal URT Some Serovars

Virulence
5 and 13 Death in 96 Hours
4 Severe Polyserositis and Arthritis
Glasser's Disease (Porcine Polyserositis and Arthritis)

All Forms

Epidemiology
EARLY COLONIZATION
Nasal Cavity Healthy Pigs

VIRULENCE VARIES with SEROTYPE

CROSS PROTECTION POOR Amoung Serotypes

INCUBATION ULTRA SHORT
12 - 24 Hours PI

MULTIPLE SEROTYPES
May Infect a Single Pig
Glasser's Disease (Porcine Polyserositis and Arthritis)

Peracute

Clinical Signs
Death PERACUTE
Glasser's Disease (Porcine Polyserositis and Arthritis)

Acute

Clinical Signs
Convulsions

Recumbancy

Joint Swelling and Pain

Pyrexia
High 40.5 to 42

Anorexia

Depression

CYANOSIS

Edema
Glasser's Disease (Porcine Polyserositis and Arthritis)


Chronic

Clinical Signs
Lameness

Coughing

Dyspnea

WEIGHT LOSS

Passive Immunity Wanes
Glasser's Disease (Porcine Polyserositis and Arthritis)

All Forms

Pathogenesis
COLONIZES
Nasal Cavity
Trachea

PURULENT RHINITIS
Focal Loss of Cilia
Inflammation of Nasal and Tracheal Mucosa

SEPTICEMIA Follows Epithelial Invasion

PHAGOCYTOSIS IMPEDED BY CAPSULE

POLYSEROSITIS FIBRINOSUPPURATIVE

DIC Peracute
Glasser's Disease (Porcine Polyserositis and Arthritis)

All Forms

Diagnosis

Pathology
FIBRINOSUPPURATIVE
Exudates
(Bread and Butter Lesions)

SEROSAL SURFACE Inflammation
Single or Multiple,
Peritoneum,
Pericardium,
Pleura,
Articular Surfaces,
Meninges

Septicemia
Occasionally WITHOUT Serosal Inflammation

Cellulitis
Occasionally WITHOUT Serosal Inflammation

Meningitis
Occasionally WITHOUT Serosal Inflammation
Glasser's Disease (Porcine Polyserositis and Arthritis)


All Forms

Diagnosis

History
Mixing Stock,
New Arrivals

Especially High Health Herds
Glasser's Disease (Porcine Polyserositis and Arthritis)

All Forms

Diagnosis

CULTURE
CAN BE DIFFICULT
Fastidious Nature

Treated Animals NIET

SUBMIT UNTREATED PIGS Best

Fresh or Frozen Samples

Requirements
CO2 Enrichment,
Choclate or Blood Agar,
Staphylococcal Streak
Glasser's Disease (Porcine Polyserositis and Arthritis)

All Forms

Diagnosis

SEROTYPING
Capsular AG

Helps Deterimine Virulence of Isolates

Many NON Typable

SEROTYPE SPECIFIC ELISA
Can be Developed for Herd Investigation
Glasser's Disease (Porcine Polyserositis and Arthritis)

All Forms

Diagnosis

PCR (ERIC)
DNA Finger Printing

Useful to Select Strains for
Autogenous Vaccination

Genetic Relationships of Multiple Strains

Virulence Evaluation NIET
Glasser's Disease (Porcine Polyserositis and Arthritis)

All Forms

Treatment
Antimicrobial
Resistance Patterns Change

Antimicrobial
Generally Sensitive
B-Lactams
Tetracyclines
TMS

Antimicrobial Parenteral
Early Tx Essential for Sick Animals
Prognosis Guarded

Antimicrobial Water Prophylaxis
Caution Re Lameness, Illness

Antimicrobial Feed Prophylaxis
Caution Re Lameness, Illness
Glasser's Disease (Porcine Polyserositis and Arthritis)

All Forms

Control

Vaccination Injection
CROSS PROTECTION
POOR AMOUNG SEROTYPES

COMMERCIAL
SEROTYPES VARY WITH PRODUCT
(4 or 4 and 5)

AUTOGENOUS EFFECTIVE
SEROTYPES of IMPORTANCE for FARM

Maternal AB Important for Young Pigs

Protects Against Dz
NOT Colonization
Swine Erysipelas

All Forms

Agent
Erysipelothrix rhusiopathiae
Swine Erysipelas

All Forms

Etiology
Servovars 26

Swine Serovars 80% 1 (main) and 2

CARRIERS
30% to 50% of Healthy Swine
Tonsil,
Lymph Nodes

Also Isolated
Sheep,
Turkeys
Fish (tf +/- Feed Contamination)

ZOONOTIC POTENTIAL
Erysipeloid Skin Lesions
DDx Strep Cellulitis
Meat Plant, Leather, Rendering
Swine Erysipelas

All Forms

Epidemiology
Persistence Environment RESISTANT to DRYING

SUSCEPTABLE DISINFECTANTS

Persistence TISSUE (Frozen, Chilled, Carcasses, Feces)
MONTHS

ALL AGES AFFECTED

Acutely Infected Swine SHED PROFUSELY

PASSIVE AB PROTECTIVE

MATERNAL AB INTERFERENCE
May Interfere with Vaccine Induced Active Immunity

90% of Sows Develop Dz 1 Week Pre Farrowing
tf High Maternal AB
tf Vaccinate AFTER 6 to 8 Weeks Age
Swine Erysipelas

Peracute / Acute

Clinical Signs
DEATH PERACUTE
Often Initial Manifistation

PYREXIA 41 to 42.5

Depression

RELUCTANCE TO MOVE
Shifting Weight from Leg to Leg

DIAMOND SKIN DZ
Localized Hyperemia →
Edema (Good Time to Culture) →
Piloerection →
Cyanosis →
Ischemic Necrosis (Too Late to Culture)

Acute Ischemic Necrosis
Wide Spread
Severe Dz
Swine Erysipelas

Chronic Arthritis

Clinical Signs
SYNOVITIS
Acutely (4 to 10 Days)
Non Suppurative

SYNOVIAL PROLIFERATION

Fibrinous Exudation

Articular Cartilage - Pannus Formation
FIBROSIS and DESTRUCTION
3 to 8 Months

Lameness
Weight Bearing to Non Weigh Bearing
Swine Erysipelas

Chronic Endocarditis

Pathogenesis
Vasculitis
MYOCARDIAL INFACRTS

BACTERIAL EMBOLI

Fibrin Deposition

Destruction of Valvular Endocardium

ENDOCARDITIS VEGETATIVE VALVULAR
Swine Erysipelas

Chronic Endocarditis

Clinical Signs
Death Acute

Cardiac Insufficiency

Exercise Intolerance

Cyanosis
Peripheral Tissue

Dyspnea
Swine Erysipelas

All Forms

Pathogenesis
INCUBATION
SHORT (36 Hours)

ENDOTHELIAL SWELLING
(Early Edema)

Monocyte Adherence
VASCULITIS Systemic

THROMBOSIS FIBRINOUS
NECROSIS

DIAPEDESIS

SEPTICEMIA PERACUTE DEATH

LOCALIZATION Chronic
SKIN,
JOINTS,
HEART
Swine Erysipelas

All Forms

Diagnosis

Pathology
VILLONODULAR HYPERTROPHY
Finisher

VASCULITIS

THROMBOSIS

DERMATITIS
NECROTIZING (+/- Pale Centre)

ENDOCARDITIS VALVULAR Chronic

NON SUPPURATIVE ARTHRITIS Chronic Fibrosing
Hips,
Elbow,
Stifle

SEPTICEMIA Parenchymal Organs

Epicardium Petechial and Ecchymotic Hemorrhage

Spleen Enlarged, Congested

Kidney Petechial Hemorrhage

Liver Turkey Egg Millary Foci
Swine Erysipelas

All Forms

Diagnosis

Culture
Peracute / Acute
SYSTEMIC SITES Live Animal LN,
Liver,
Spleen

ACUTE SKIN LESIONS
(Pink or White NOT Purple) Junctional Biopsy

BLOOD CULTURE EDTA Serum
Several Septicemic Animals


Arthritis
Difficult
Best = VILLONODULAR SYNOVIAL TISSUE
Synovial Fluid


Endocarditis
Best Yield
Culture Lesion
Swine Erysipelas

All Forms

Treatment
Antimicrobial Parenteral
Required for OVERT DZ
Penicillin G Most Common
Tetracyclines
RAPID Recovery 12 to 24 Hours for Downers Diagnostic


Antimicrobial Water
Variable Success Acute Outbreaks
+/- Intake via Reluctance to Move
Tetracyclines
Amoxicillin
Swine Erysipelas

All Forms

Control
HYGIENE and SANITATION

Infected Pigs SHED PROFUSELY

SUSCEPTIBLE to DISINFECTANTS
Swine Erysipelas

All Forms

Control

Vaccination Injection

BREEDING HERD
Killed Bacterins

Pre Breeding

Pre Farrowing
Swine Erysipelas

All Forms

Control

Vaccination Injection

FEEDING HERD
Killed Bacterins

BoosteredVaccination
Nursery Early Grower

Recommended in Face of Outbreak

Poor Efficacy Chronic Dz
Swine Erysipelas

All Forms

Control

Vaccination Oral
Water System

Live Avirulent

NOT Recommended Acute Outbreak
Actinobacillus suis

All Forms

Etiology
Endemic

Sporadic Dz

Mimics ES and APP
Actinobacillus suis

All Forms

Epidemiology
Carriers
Healthy Sows
VAGINA

Transmission Vertical
Possible During Farrowing

Transmission Horizontal Main

Carriers
Healthy Pigs of ANY Age
Nasal Cavities
Tonsil

EARLY COLONIZATION
Upper Respiratory Tract
Neonates

MORTALITY
SEPTICEMIA
Suckling Pigs
Weaned Pigs

SEVERITY DECREASES with Age
Actinobacillus suis

Peracute / Acute

Clinical Signs
SEPTICEMIA
Multiple Piglets in Litter
Suckling,
Early Nursery

DEATH PERACUTE
Grower, Finisher,
Adults
(Less Common)
Actinobacillus suis

Chronic

Clinical Signs
Suckling, Early Nursery

ENDOCARDITIS Mimics
Strep suis,
Erysipelas

SKIN LESIONS Mimics Erysipelas
(Occasionally Diamond)

Arthritis

Pododermatitis


Grower, Finisher, Adults (Less Common)

PNEUMONIA FOCAL NECROTIZING
Mimics APP

SKIN LESIONS Mimics
Erysipelas,
PDNS
Actinobacillus suis

All Forms

Pathogenesis
SEPTIC EMBOLI
Systemic Dissemination

VASCULAR HEMORRAGE NECROSIS
Actinobacillus suis

All Forms

Diagnosis

Pathology
SEPTICEMIA

Serofibrinous Effusions

Petechial and Ecchymotic Hemorrhages

Pleuritis

Pericarditis

Milary Abscesses
Multi Focal White Foci

PNEUMONIA Embolic NECROTIZING

HEMORRHAGIC
SKIN LESIONS
Ischemic and Necrotic

ENDOCARDITIS Valvular

ARTHRITIS
Actinobacillus suis

All Forms

Diagnosis
Culture
ESSENTIAL for Confirmation

Clinical Signs
Pathology Non Specific

Serology NIET

Immuno Histo Chemistry NIET

PCR NIET
Actinobacillus suis

All Forms

Treatment
Antimicrobial Parenteral
Penicillin G
Tetracyclines

Antimicrobial Feed
Penicillin G
Tetracyclines

Antimicrobial Water
Penicillin G
Tetracyclines
Actinobacillus suis

All Forms

Control
Vaccination Injection Commercial NOT Available

Vaccination Injection Autogenous VARIABLE Efficacy
PDNS Procine Dermatitis and Nephropathy Syndrome

Epidemiology
Associated with PCVD and PCVAD Outbreaks

Sporadic in Canada UNTIL 2004
Increased Prevalence via PCVD

Differentiate
ERYSIPELAS (Skin Lesions),
CLASSIC SWINE FEVER (Kidney Lesions),
SEPTICEMIAS
PDNS Procine Dermatitis and Nephropathy Syndrome

Etiology
Suggested

PCV2,
PRRS,
Pasteurella multocida,
Streptococcus sp.,
LPS via Gram -ve,
Non Infectious,
Environmental Factors
PDNS Procine Dermatitis and Nephropathy Syndrome

Pathogenesis
VASCULITIS Systemic

NECROTIZING SKIN and KIDNEY

HYPERSENSITIVITY TYPE 3

IMMUNE COMPLEX DEPOSITION
Vascular and Glomerular Capillary Endothelium

NEPHRITIS GLOMERULAR
PDNS Procine Dermatitis and Nephropathy Syndrome

Clinical Signs
OLDER Animals Typically
Grower, Finisher, Young Breeding Stock

SEVERE to MILD Dz

DEATH PERACUTE

Pyrexia

SKIN LESIONS
CYANOTIC DEEPLY SO
Smaller,
Flat,
NO Central Pallor

Lameness

Anorexia

Weight Loss

SPONTANEOUS RECOVERY
Over Several Weeks
Mild Dz
PDNS Procine Dermatitis and Nephropathy Syndrome

Diagnosis

Pathology

Skin
RED / PURPLE

Round / IRREGULAR

COALESCE to Patches

NOT Diamond

Not Pink or White

NO Piloerection

Usually Darker than Erysipelas

INITIALLY
HIND QUARTERS,
LIMBS,
ABDOMEN
Then Spread Cranially

Heal over Time (3 to 4 Weeks)
PDNS Procine Dermatitis and Nephropathy Syndrome

Diagnosis

Pathology

Kidney
ENLARGED

MOTTLED

PETECHIAL HEMORRHAGE

Subcasular on Cortex

Turkey Egg Millary Foci
(DDx Lepto, CSF)
PDNS Procine Dermatitis and Nephropathy Syndrome

Diagnosis

Pathology

Systemic
SEROUS EFFUSIONS
Body Cavities,
SC Edema

PETECHIAL-ECCHYMOTIC HEMORRHAGES
Diffuse

LN Enlarged
PDNS Procine Dermatitis and Nephropathy Syndrome

Treatment
NIET
PDNS Procine Dermatitis and Nephropathy Syndrome

Control
NIET